These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15175526)

  • 1. Tobacco harm reduction: what do the experts think?
    Martin EG; Warner KE; Lantz PM
    Tob Control; 2004 Jun; 13(2):123-8. PubMed ID: 15175526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The US tobacco control community's view of the future of tobacco harm reduction.
    Warner KE; Martin EG
    Tob Control; 2003 Dec; 12(4):383-90. PubMed ID: 14660773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community tobacco control leaders' perceptions of harm reduction.
    Joseph AM; Hennrikus D; Thoele MJ; Krueger R; Hatsukami D
    Tob Control; 2004 Jun; 13(2):108-13. PubMed ID: 15175521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory issues concerning the development and circulation of nicotine-containing products: a qualitative study.
    Rooke C; McNeill A; Arnott D
    Nicotine Tob Res; 2013 Jun; 15(6):1052-9. PubMed ID: 23128517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financial Conflicts of Interest and Stance on Tobacco Harm Reduction: A Systematic Review.
    Hendlin YH; Vora M; Elias J; Ling PM
    Am J Public Health; 2019 Jul; 109(7):e1-e8. PubMed ID: 31095414
    [No Abstract]   [Full Text] [Related]  

  • 6. Lessons from the history of tobacco harm reduction: The National Cancer Institute's Smoking and Health Program and the "less hazardous cigarette".
    Parascandola M
    Nicotine Tob Res; 2005 Oct; 7(5):779-89. PubMed ID: 16191749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obsolete tobacco control themes can be hazardous to public health: the need for updating views on absolute product risks and harm reduction.
    Kozlowski LT; Abrams DB
    BMC Public Health; 2016 May; 16():432. PubMed ID: 27221096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tobacco, nicotine and harm reduction.
    Le Houezec J; McNeill A; Britton J
    Drug Alcohol Rev; 2011 Mar; 30(2):119-23. PubMed ID: 21375611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The place for harm reduction and product regulation in UK tobacco control policy.
    Gilmore AB; Britton J; Arnott D; Ashcroft R; Jarvis MJ
    J Public Health (Oxf); 2009 Mar; 31(1):3-10. PubMed ID: 19109341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Zealand policy experts' appraisal of interventions to reduce smoking in young adults: a qualitative investigation.
    Ball J; Hoek J; Tautolo ES; Gifford H
    BMJ Open; 2017 Dec; 7(12):e017837. PubMed ID: 29229655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Harm reduction strategy in tobacco control].
    Gorini G
    Epidemiol Prev; 2011; 35(3-4 Suppl 1):19-32. PubMed ID: 21926451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Will the next generation of "safer" cigarettes be safer?
    Warner KE
    J Pediatr Hematol Oncol; 2005 Oct; 27(10):543-50. PubMed ID: 16217258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does dual use jeopardize the potential role of smokeless tobacco in harm reduction?
    Frost-Pineda K; Appleton S; Fisher M; Fox K; Gaworski CL
    Nicotine Tob Res; 2010 Nov; 12(11):1055-67. PubMed ID: 20847148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Support for a tobacco endgame and increased regulation of the tobacco industry among New Zealand smokers: results from a National Survey.
    Edwards R; Wilson N; Peace J; Weerasekera D; Thomson GW; Gifford H
    Tob Control; 2013 May; 22(e1):e86-93. PubMed ID: 22535362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Australian urban Indigenous smokers' perspectives on nicotine products and tobacco harm reduction.
    Yuke K; Ford P; Foley W; Mutch A; Fitzgerald L; Gartner C
    Drug Alcohol Rev; 2018 Jan; 37(1):87-96. PubMed ID: 28493405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimising the harm from nicotine use: finding the right regulatory framework.
    Borland R
    Tob Control; 2013 May; 22 Suppl 1(Suppl 1):i6-9. PubMed ID: 23591515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No sisyphean task: how the FDA can regulate electronic cigarettes.
    Paradise J
    Yale J Health Policy Law Ethics; 2013; 13(2):326-74. PubMed ID: 24340824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobacco harm reduction: promise and perils.
    Warner KE
    Nicotine Tob Res; 2002; 4 Suppl 2():S61-71. PubMed ID: 12580158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward a comprehensive policy on nicotine delivery products and harm reduction.
    Solyst J
    Food Drug Law J; 2012; 67(4):393-404, i. PubMed ID: 24640613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Origins of tobacco harm reduction in the UK: the 'Product Modification Programme' (1972-1991).
    Elias J; Ling PM
    Tob Control; 2018 Jul; 27(e1):e12-e18. PubMed ID: 29330172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.